Luskin A, Griffin NM, Wagele-Steffen A, et al. Decreased exacerbations and hospitalizations in adolescents enrolled in PROSPERO (Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). ATS 2017, abstract A5104.
Associatie tussen duur van immuuntherapie en overleving bij gevorderd NSCLC
okt 2023 | Immuuntherapie, Longoncologie